WHO ICTRP trial
?Effect of Sildenafil and estradiol valerate on increasing endometrial thickness
IRCT20210313050688N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20210313050688N1 |
|---|---|
| Public title | ?Effect of Sildenafil and estradiol valerate on increasing endometrial thickness |
| Scientific title | The effect of Sildenafil and estradiol valerate on increasing endometrial thickness before intra uterine insemination |
| Primary sponsor | Ardabil University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Female infertility due to nonimplantation of ovum. Female infertility of uterine origin;N97.2 |
| Interventions | Intervention 1: Control group: Patients of this group will receive An Estradiol valerate tablet every 12 hours from the 10th day of menstruation to the initiation of ovulation(10days) and also, they will receive Placebo gel vaginally from… |
| Registration date | May 17, 2021 |
| Target size | 100 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: